Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Expanded Recommendations for OBRONA

24 Jul 2024 07:00

RNS Number : 5304X
Plant Health Care PLC
24 July 2024
 

24 July 2024

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Expanded Recommendations to Support Commercial Sales of OBRONA® Biochemical Fungicide for Use on Corn, Soybean, and Wheat

  

Plant Health Care® (AIM.PHC.L), a leading provider of peptides used by growers to improve crop production and quality within global agriculture markets, is pleased to announce the issuance of new recommendations for use of OBRONA® biochemical fungicide to provide farmers with another tool to control a wide range of diseases and improve crop yield and harvest quality in corn, soybean and wheat in key US states.

 

Highlights:

- The new Section 2(ee) recommendations cover the use of OBRONA to control diseases in the following crops:

· Control in corn of common rust, gray leaf spot, northern and southern corn leaf blight and tar spot,

· Control in soybean of downy mildew, frogeye leaf spot, sclerotinia stem rot, and white mold,

· Control in wheat of multiple rust species: black, leaf, stem, stripe, and yellow rust. 

- These diseases represent serious threats to agricultural production and can significantly reduce crop yields, harvest quality, and grower profitability if not properly managed. OBRONA provides growers with a novel mode of action and an environmentally friendly tool to control these diseases and support sustainable agriculture based on reduced reliance on established synthetic pesticides. 

 

Section 2(ee) of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) allows users to apply pesticides under certain limited conditions that are not specified on the commercial label. The recommendations shown above have been written to address control of target pests not listed on the OBRONA label.

 

Compared to current biocontrol products, OBRONA provides highly consistent and convenient product performance to control a broad spectrum of fungal and bacterial plant diseases. In addition to providing growers with a favorable return on investment, OBRONA brings growers convenience as it is compatible with many commonly used fungicides, herbicides, and insecticides in tank-mix and sequential application programs. OBRONA has no special requirements for storing or handling, which allows greater flexibility within the distribution channel and ease of on-farm application.

  

Jeff Tweedy, CEO of Plant Health Care, said: ‟Wilbur-Ellis is aggressively launching OBRONA this summer across the mid-west for disease control in corn, soybean and wheat. Results from field testing of OBRONA are very promising and we are excited to continue working with Wilbur-Ellis to bring the benefits of OBRONA to a wide range of growers across the country for the 2024 season."

 

  

# # #

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

 

Tel: +1 919 926 1600

 

 

Cavendish Capital Markets Limited - Nomad & Broker Neil McDonald / Pete Lynch

 

Tel: +44 (0) 131 220 9771

 

 

For further information about Wilbur-Ellis, please contact: Jeanne Forbis, jforbis@wilburellis.com

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, sugarcane, potatoes, rice, and wheat, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors, and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

About the Wilbur-Ellis Companies 

Founded in 1921, the Wilbur-Ellis companies are leading marketers, distributors and manufacturers of agricultural products and animal nutrients. By developing strong relationships, making strategic market investments, and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales of over $3.5 billion. For more information, please visit www.wilburellis.com

Wilbur-Ellis Agriculture, with annual sales revenue of $2.5 billion, has over 150 retail locations throughout the U.S.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAQKNBKABKDQOB
Date   Source Headline
14th Sep 20157:00 amRNSHalf Yearly Report
19th Aug 20157:00 amRNSBlocklisting Interim Review
13th Jul 20157:00 amRNSPHC Granted Product Registration in Brazil
18th Jun 20157:00 amRNSDirector/PDMR Shareholding
17th Jun 20152:20 pmRNSResult of AGM
2nd Jun 20157:00 amRNSRe Agreement
6th May 20157:01 amRNSPlant Health Care Hires Jeff Tweedy
30th Apr 20153:02 pmRNSTotal Voting Rights
22nd Apr 20153:05 pmRNSTR1: Notificiation of Major Interest in Shares
17th Apr 20157:00 amRNSDIRECTORS' DEALING
15th Apr 20157:00 amRNSAnnual Report 2014 and Notice of AGM
8th Apr 20157:00 amRNSRe Agreement
30th Mar 20157:00 amRNSAnnual Financial Report
27th Mar 20157:00 amRNSDirectorate Change
5th Mar 201512:30 pmRNSPlant Health Care signs Distribution Agreement
20th Feb 20155:48 pmRNSBlocklisting Interim Review
17th Feb 20154:03 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSBoard changes and trading update
15th Dec 20141:51 pmRNSTR-1: Notification of Major Interest in Shares
5th Dec 20147:00 amRNSPHC Signs Agreement With Arysta LifeScience
19th Nov 20147:00 amRNSPlant Health Care Hires LHA
11th Nov 20144:05 pmRNSHolding(s) in Company
30th Oct 20147:00 amRNSPHC & Sipcam Enter Agreement
27th Oct 20147:00 amRNS3G Peptide Technology Platform shows major promise
23rd Oct 20144:29 pmRNSHolding(s) in Company
6th Oct 201411:25 amRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSDirector/PDMR Shareholding
15th Sep 20147:00 amRNSHalf Yearly Report
19th Aug 201410:28 amRNSAIM Blocklisting Return
12th Aug 20143:10 pmRNSTR-1 Notification of Major Interest in Shares
22nd Jul 20144:10 pmRNSTR-1 Notification of Major Interest in Shares
30th Jun 20149:18 amRNSTotal Voting Rights
5th Jun 201412:45 pmRNSTR-1 Notification of Major Interest in Shares
22nd May 20147:00 amRNSDelisting of shares from the CISX
8th May 20141:30 pmRNSAGM Voting Results
15th Apr 201411:30 amRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSDirector/PDMR Shareholding
9th Apr 20142:15 pmRNSDirector's Dealing - Grant of Share Options
9th Apr 20142:00 pmRNSTR-1 Notification of Major Interest in Shares
7th Apr 20145:15 pmRNSPublication of Annual Report 2013 & Notice of AGM
31st Mar 20143:45 pmRNSTotal Voting Rights
24th Mar 20147:00 amRNSPreliminary Results
3rd Mar 20144:35 pmRNSPrice Monitoring Extension
28th Feb 20141:00 pmRNSTotal Voting Rights
19th Feb 201412:15 pmRNSBlocklisting Interim Review
17th Feb 20149:45 amRNSTR-1 Notification of Major Interest in Shares
6th Feb 20144:40 pmRNSSecond Price Monitoring Extn
6th Feb 20144:35 pmRNSPrice Monitoring Extension
31st Jan 20143:00 pmRNSTotal Voting Rights
15th Jan 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.